Gene · 23526
Papers2,040
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
141 to 160 of 2,040
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Current and future concepts for the generation and application of genetically engineered CAR-T and TCR-T cells. | Front Immunol | 2023 | 36949949 | PubTator, text mining | PubMed |
| Bivalent vaccines effectively protect mice against influenza A and respiratory syncytial viruses. | Emerg Microbes Infect | 2023 | 36927227 | PubTator, text mining | PubMed |
| Antiviral Effect of Ginsenosides rk1 against Influenza a Virus Infection by Targeting the Hemagglutinin 1-Mediated Virus Attachment. | Int J Mol Sci | 2023 | 36902398 | PubTator, text mining | PubMed |
| Transgenic HA-1-Specific CD8+ T-Lymphocytes Selectively Target Leukemic Cells. | Cancers (Basel) | 2023 | 36900382 | PubTator, text mining | PubMed |
| Deep-HAR: an ensemble deep learning model for recognizing the simple, complex, and heterogeneous human activities. | Multimed Tools Appl | 2023 | 36851913 | PubTator, text mining | PubMed |
| Hyaluronic Acid-Coated Chitosan Nanoparticles as an Active Targeted Carrier of Alpha Mangostin for Breast Cancer Cells. | Polymers (Basel) | 2023 | 36850308 | PubTator, text mining | PubMed |
| Molecular basis for differential activation of p101 and p84 complexes of PI3Kγ by Ras and GPCRs. | Cell Rep | 2023 | 36842083 | PubTator, text mining | PubMed |
| Voluntary Surveillance Program for Equine Influenza Virus in the United States during 2008-2021. | Pathogens | 2023 | 36839464 | PubTator, text mining | PubMed |
| First Impressions Matter: Immune Imprinting and Antibody Cross-Reactivity in Influenza and SARS-CoV-2. | Pathogens | 2023 | 36839441 | PubTator, text mining | PubMed |
| Low prevalence of influenza viruses and predominance of A(H3N2) virus with respect to SARS-CoV-2 during the 2021-2022 season in Bulgaria. | J Med Virol | 2023 | 36832544 | PubTator, text mining | PubMed |
| X or Y Cancer: An Extensive Analysis of Sex Differences in Lung Adenocarcinoma. | Curr Oncol | 2023 | 36826068 | PubTator, text mining | PubMed |
| Human iPSC-derived preclinical models to identify toxicity of tumor-specific T cells with clinical potential. | Mol Ther Methods Clin Dev | 2023 | 36816758 | PubTator, text mining | PubMed |
| Mutation-class dependent signatures outweigh disease-associated processes in cystic fibrosis cells. | Cell Biosci | 2023 | 36759923 | PubTator, text mining | PubMed |
| Sequential genome-wide CRISPR-Cas9 screens identify genes regulating cell-surface expression of tetraspanins. | Cell Rep | 2023 | 36724073 | PubTator, text mining | PubMed |
| Next-generation antigen-presenting cell immune therapeutics for gliomas. | J Clin Invest | 2023 | 36719372 | PubTator, text mining | PubMed |
| Physiological and growth responses of cacao to glyphosate exposure. | J Environ Sci Health B | 2023 | 36708092 | PubTator, text mining | PubMed |
| Influenza vaccine effectiveness against influenza A subtypes in Europe: Results from the 2021-2022 I-MOVE primary care multicentre study. | Influenza Other Respir Viruses | 2023 | 36702797 | PubTator, text mining | PubMed |
| INFINITy: A fast machine learning-based application for human influenza A and B virus subtyping. | Influenza Other Respir Viruses | 2023 | 36702796 | PubTator, text mining | PubMed |
| Allogeneic stem cell transplantation in the treatment of acute myeloid leukemia: An overview of obstacles and opportunities. | World J Clin Cases | 2023 | 36686358 | PubTator, text mining | PubMed |
| Endosomal escape of RNA therapeutics: How do we solve this rate-limiting problem? | RNA | 2023 | 36669888 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/23526/papers?page=8